Loading organizations...
§ Private Profile · Redwood City, CA, USA
SaaS provider unifying and analyzing clinical trial data for life sciences and biopharma, focused on real-time insights.
Comprehend has raised $21.0M across 1 funding round.
Key people at Comprehend.
Comprehend was founded in 2010 by Rick Morrison (Founder/CEO).
Comprehend has raised $21.0M in total across 1 funding round.
Based in Redwood City, California, Comprehend provides cloud-based software-as-a-service solutions designed to unify, monitor, and analyze complex clinical trial data from disparate sources in real-time. The enterprise platform delivers automated insights and risk monitoring capabilities for clinical operations, data management, and medical review teams at biopharma, medical device, and clinical research organizations. Prior to its strategic acquisition, the software company scaled its workforce to 51 employees and secured multiple financing rounds, including a $1.2 million seed round and an $8.4 million Series A investment. Comprehend received financial backing from prominent venture capital firms such as Sequoia Capital, Lightspeed Venture Partners, and Eminence Capital before ultimately being acquired by Saama Technologies in August 2019. The organization was originally founded in 2010 by Rick Morrison following its participation in the Winter 2011 Y Combinator accelerator batch.
Key people at Comprehend.
Comprehend has raised $21.0M across 1 funding round. Most recently, it raised $21.0M Series B in August 2014.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 18, 2014 | $21M Series B | Peter Nieh | Sequoia Capital | Announced |
Comprehend was founded in 2010 by Rick Morrison (Founder/CEO).
Comprehend has raised $21.0M in total across 1 funding round.
Comprehend's investors include Peter Nieh, Sequoia Capital.
Comprehend is a SaaS company that provides cloud-based clinical intelligence solutions designed to increase the speed, safety, and quality of clinical trials. Its software suite supports clinical operations, data management, medical data review, and monitoring by unifying and analyzing clinical data from disparate sources in real time. This enables clinical research organizations (CROs), pharmaceutical, biotechnology, and medical device companies to reduce risks, meet milestones on time, and stay within budget. Comprehend’s platform delivers actionable insights for risk monitoring, centralized monitoring, and medical review, helping accelerate drug development and improve patient outcomes[1][3][5].
Founded in 2010 and headquartered in Redwood City, California, Comprehend was acquired by Saama Technologies in 2019, combining forces to create a leading clinical analytics platform powered by AI. Its investors included top-tier venture capital firms such as Sequoia Capital and Lightspeed Venture Partners. The company serves life sciences organizations aiming to optimize clinical trial processes, reduce costs, and enhance data quality and regulatory compliance[1][3][4].
---
Comprehend was founded in 2010 by Rick Morrison, who serves as CEO. The company emerged from the need to address inefficiencies and risks in clinical trials by providing a unified, cloud-based platform that could integrate and analyze clinical data in real time across multiple sources. Early traction came from its ability to deliver actionable risk and performance insights that helped sponsors and CROs reduce trial delays and costs. Over time, Comprehend evolved from a standalone SaaS provider to becoming part of Saama Technologies, enhancing its AI-driven clinical data analytics capabilities and expanding its market reach[1][3][4].
---
---
Comprehend rides the growing trend of digital transformation and AI integration in clinical development, where real-time data analytics and risk-based monitoring are becoming critical to reducing the high costs and lengthy timelines of drug development. The timing is favorable due to increasing regulatory emphasis on data quality and patient safety, alongside the industry's push for decentralized and risk-based trial monitoring. By enabling seamless data integration and actionable insights, Comprehend influences the broader life sciences ecosystem by helping sponsors and CROs optimize resource allocation, improve trial outcomes, and accelerate time to market[3][5].
---
Looking ahead, Comprehend’s integration with Saama positions it to leverage advanced AI and machine learning to further enhance clinical trial analytics, predictive risk management, and operational efficiencies. Trends such as decentralized trials, real-world data incorporation, and regulatory demands for transparency will shape its evolution. Its influence is likely to grow as life sciences companies increasingly adopt cloud-based, AI-driven platforms to meet the challenges of modern drug development. Comprehend’s mission to accelerate treatments to patients aligns with the broader industry imperative to bring safer, more effective therapies to market faster[3].
This trajectory underscores Comprehend’s role as a pivotal enabler of clinical trial innovation, transforming complex data into actionable intelligence that drives better decisions and outcomes.
